Introducing Aeran Melancon
Published 03/13/2023
With each new intern rotation, our hope is that working with us will gain valuable knowledge. Learn More
Digitally transforming the undiagnosed patient identification market for rare and genetic conditions
Welcome to ThinkGenetic
ThinkGenetic's goal is to speed time to diagnosis for genetic and rare conditions and reduce the chances of diagnostic error - two things that can make a significant difference for millions of people around the world. ThinkGenetic utilizes Natural Language Processing, statistical modeling, and proprietary algorithms to identify individuals at-risk of having a genetic disease. The ThinkGenetic experts have developed two validated solutions to identify at-risk patients: one through electronic health records, FindEHR, and the consumer-focused tool, SymptomMatcher.
Our validated products are sensitive and specific enough to flag patients at increased risk to have a genetic diagnosis and include targeted information to educate providers quickly and efficiently about available sponsored testing, enrolling clinical trials, referral to genetics, and FDA approved treatments. De-identified, HIPAA-compliant, summary data can then be shared with our pharma clients to supplement their sales and marketing efforts while benefiting the patients and assisting their clinicians to explore possible genetic diagnoses.
ThinkGenetic News
ThinkGenetic to Attend ACMG/SIMD Joint Meeting
Published 03/10/2023
ThinkGenetic team members will be participating in continuing education and networking. Learn More
WORLDSymposium 2023
Published 02/08/2023
Chief Genetic Officer Dawn Laney to participate in Symposia panel on Phenotypic Variability for LSD. Learn More
ThinkGenetic Announces Chief Revenue Officer
Published 02/07/2023
Cian Robinson joins ThinkGenetic to focus on growth and rartnership opportunities. Learn More
